OneDigital Investment Advisors LLC Invests $207,000 in Encompass Health Co. (NYSE:EHC)

OneDigital Investment Advisors LLC acquired a new stake in shares of Encompass Health Co. (NYSE:EHC) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,143 shares of the company’s stock, valued at approximately $207,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Commonwealth Equity Services LLC grew its holdings in shares of Encompass Health by 1.3% during the second quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company’s stock worth $845,000 after purchasing an additional 123 shares in the last quarter. V Square Quantitative Management LLC grew its stake in Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after buying an additional 140 shares in the last quarter. O Shaughnessy Asset Management LLC increased its holdings in shares of Encompass Health by 3.9% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 4,246 shares of the company’s stock worth $351,000 after buying an additional 160 shares during the last quarter. Verdence Capital Advisors LLC increased its holdings in shares of Encompass Health by 4.6% in the 3rd quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company’s stock worth $355,000 after buying an additional 160 shares during the last quarter. Finally, Mount Yale Investment Advisors LLC raised its position in shares of Encompass Health by 6.6% during the 2nd quarter. Mount Yale Investment Advisors LLC now owns 2,749 shares of the company’s stock valued at $236,000 after buying an additional 170 shares in the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms recently commented on EHC. UBS Group increased their target price on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, September 25th. Royal Bank of Canada increased their price objective on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Stephens reissued an “overweight” rating and set a $105.00 price objective on shares of Encompass Health in a report on Tuesday, August 6th. Barclays upped their target price on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Finally, Truist Financial reissued a “buy” rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Encompass Health presently has an average rating of “Buy” and an average target price of $107.11.

Encompass Health Price Performance

Shares of Encompass Health stock opened at $101.12 on Friday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. Encompass Health Co. has a one year low of $63.78 and a one year high of $104.55. The business’s 50 day simple moving average is $97.11 and its two-hundred day simple moving average is $90.84. The stock has a market capitalization of $10.19 billion, a P/E ratio of 24.43, a price-to-earnings-growth ratio of 1.32 and a beta of 0.88.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.86 earnings per share. Analysts forecast that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. Encompass Health’s dividend payout ratio is currently 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.